Investigation of transport of genistein, daidzein and their inclusion complexes prepared with different cyclodextrins on Caco-2 cell line

被引:22
|
作者
Daruhazi, Agnes Emma [1 ]
Kiss, Timea [2 ]
Vecsernyes, Miklos [2 ]
Szente, Lajos [3 ]
Szoke, Eva [1 ]
Lemberkovics, Eva [1 ]
机构
[1] Semmelweis Univ, Dept Pharmacognosy, H-1085 Budapest, Hungary
[2] Univ Debrecen, Dept Pharmaceut Technol, Med & Hlth Sci Ctr, H-4032 Debrecen, Hungary
[3] CycloLab Ltd, H-1097 Budapest, Hungary
关键词
Genistein; Daidzein; Dissolution profile; Caco-2; Cyclodextrin; PHYTOESTROGENS; ISOFLAVONOIDS;
D O I
10.1016/j.jpba.2013.05.012
中图分类号
O65 [分析化学];
学科分类号
070302 ; 081704 ;
摘要
Isoflavonoids are widespread constituents in medical plants especially in legumes (Fabaceae), but occur in other different plant families as well (Rosaceae, Iridaceae, Amaranthaceae). Their antioxidant, estrogen-like, anti-inflammatory and analgesic effects make them promising compounds in therapy of important disorders especially in estrogen related diseases. Poor solubility in aqueous system of genistein and daidzein needs a solubility enhancement for pharmaceutical use. These compounds are suitable guest molecules for inclusion complex formation with cyclodextrins (CDs) considering matching their size and polarity. The molecular encapsulation with beta-cyclodextrin (beta-CD), gamma-cyclodextrin (gamma-CD), hydroxypropyl-beta-cyclodextrin (HP-beta-CD) and random methyl-beta cyclodextrin (RAMEB-CD) results in a solid, molecularly dispersed form and in a significantly improved aqueous solubility of genistein and daidzein. Determining enhancement in solubility and bioavailability we investigated the transport of these inclusion complexes across Caco-2 cell line comparing that of the pure compounds and found significant improving effect of the different CD derivatives on membrane permeation of the two isoflavone aglycons. (C) 2013 Elsevier B.V. All rights reserved.
引用
收藏
页码:112 / 116
页数:5
相关论文
共 50 条
  • [21] Investigation of the Uptake and Transport of Aspirin Eugenol Ester in the Caco-2 Cell Model
    Tao, Qi
    Qin, Zhe
    Liu, Xi-Wang
    Zhang, Zhen-Dong
    Li, Shi-Hong
    Bai, Li-Xia
    Li, Jian-Yong
    Yang, Ya-Jun
    FRONTIERS IN PHARMACOLOGY, 2022, 13
  • [22] ABSORPTION AND TRANSPORT OF FLUORINE FROM DIFFERENT TEAS IN A Caco-2 CELL MODEL
    Zhang, Haojie
    Fan, Yueqin
    Wen, Xiaoju
    Ni, Dejiang
    Chen, Yuqiong
    FLUORIDE, 2021, 54 (03) : 219 - 240
  • [23] Transport and Metabolism of the Tea Flavonoid (–)-Epicatechin by the Human Intestinal Cell Line Caco-2
    Jaya Bharathi Vaidyanathan
    Thomas Walle
    Pharmaceutical Research, 2001, 18 : 1420 - 1425
  • [24] Transport and metabolism of the tea flavonoid (-)-epicatechin by the human intestinal cell line Caco-2
    Vaidyanathan, JB
    Walle, T
    PHARMACEUTICAL RESEARCH, 2001, 18 (10) : 1420 - 1425
  • [25] Transport mechanisms of nicotine across the human intestinal epithelial cell line Caco-2
    Fukada, A
    Saito, H
    Inui, KI
    JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 2002, 302 (02): : 532 - 538
  • [26] Na+-dependent and -independent transport of succinate and citrate in the Caco-2 cell line
    Weerachayaphorn, J
    Pajor, AM
    FASEB JOURNAL, 2005, 19 (04): : A748 - A748
  • [27] Titanium(IV) complexes: Cytotoxicity and cellular uptake of titanium(IV) complexes on caco-2 cell line
    Hernandez, Ramon
    Mendez, Janet
    Lamboy, Jose
    Torres, Madeline
    Roman, Feliz R.
    Melendez, Enrique
    TOXICOLOGY IN VITRO, 2010, 24 (01) : 178 - 183
  • [28] Estrogens stimulate but genistein inhibits CaCO-2 colon adenocarcinoma cell proliferation
    Cole, S
    Browning, JD
    MacDonald, R
    FASEB JOURNAL, 2004, 18 (05): : A892 - A892
  • [29] Investigation of the Uptake and Transport of Two Novel Camptothecin Derivatives in Caco-2 Cell Monolayers
    Wang, Yi
    Zhang, Xiangli
    Zhuang, Wenya
    Yu, Yanlei
    Sun, Xuanrong
    Wang, Hong
    Li, Fengzhi
    Li, Qingyong
    MOLECULES, 2022, 27 (12):
  • [30] Transport Characteristics of Fexofenadine in the Caco-2 Cell Model
    Niclas Petri
    Christer Tannergren
    David Rungstad
    Hans Lennernäs
    Pharmaceutical Research, 2004, 21 : 1398 - 1404